Exploring the Causal Relationship Between Saliva Microbiota Abundance and Chronic Obstructive Pulmonary Disease/Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study.

IF 3.1 3区 医学 Q2 RESPIRATORY SYSTEM
Haixia Wei, Chunlan Han, Yongna Song
{"title":"Exploring the Causal Relationship Between Saliva Microbiota Abundance and Chronic Obstructive Pulmonary Disease/Idiopathic Pulmonary Fibrosis: A Two-Sample Mendelian Randomization Study.","authors":"Haixia Wei, Chunlan Han, Yongna Song","doi":"10.2147/COPD.S519630","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are progressive lung diseases with overlapping risk factors but distinct pathologies. This study employed bidirectional two-sample Mendelian randomization (MR) to explore potential causal relationships between saliva microbiota abundance and the risk of both diseases.</p><p><strong>Methods: </strong>Saliva microbiota abundance datasets were analyzed for forward and reverse causal associations with both diseases. Of 44 datasets, 43 met the inclusion criteria for instrumental variable selection. MR analyses were performed using inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode methods. Steiger filtering confirmed directionality. Sensitivity analyses included Cochran's Q, MR-Egger intercept, MR-PRESSO, and leave-one-out to assess heterogeneity, pleiotropy, and the influence of individual variants.</p><p><strong>Results: </strong>In forward MR, higher abundance of species <i>parvula</i> was significantly associated with reduced COPD risk (IVW OR = 0.9546, 95% CI = 0.9224-0.9879, P = 0.0020; adjusted P = 0.019). Nominal inverse associations were observed for Bacilli, <i>Porphyromonas</i>, and <i>Fusobacterium</i> with IPF, though these did not remain significant after multiple testing correction. All key associations passed Steiger directionality tests, with no evidence of horizontal pleiotropy or heterogeneity. In reverse MR, COPD showed a nominal positive association with <i>Periodonticum</i> abundance.</p><p><strong>Conclusion: </strong>This exploratory study suggests potential directional associations between specific salivary microbiota and chronic respiratory diseases. <i>Parvula</i> abundance may be protective against COPD, while Bacilli, <i>Porphyromonas</i>, and <i>Fusobacterium</i> may influence IPF risk. These findings support the salivary microbiome as a potential contributor to respiratory disease pathogenesis and warrant further validation in mechanistic and longitudinal studies.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"2801-2813"},"PeriodicalIF":3.1000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341823/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S519630","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are progressive lung diseases with overlapping risk factors but distinct pathologies. This study employed bidirectional two-sample Mendelian randomization (MR) to explore potential causal relationships between saliva microbiota abundance and the risk of both diseases.

Methods: Saliva microbiota abundance datasets were analyzed for forward and reverse causal associations with both diseases. Of 44 datasets, 43 met the inclusion criteria for instrumental variable selection. MR analyses were performed using inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode methods. Steiger filtering confirmed directionality. Sensitivity analyses included Cochran's Q, MR-Egger intercept, MR-PRESSO, and leave-one-out to assess heterogeneity, pleiotropy, and the influence of individual variants.

Results: In forward MR, higher abundance of species parvula was significantly associated with reduced COPD risk (IVW OR = 0.9546, 95% CI = 0.9224-0.9879, P = 0.0020; adjusted P = 0.019). Nominal inverse associations were observed for Bacilli, Porphyromonas, and Fusobacterium with IPF, though these did not remain significant after multiple testing correction. All key associations passed Steiger directionality tests, with no evidence of horizontal pleiotropy or heterogeneity. In reverse MR, COPD showed a nominal positive association with Periodonticum abundance.

Conclusion: This exploratory study suggests potential directional associations between specific salivary microbiota and chronic respiratory diseases. Parvula abundance may be protective against COPD, while Bacilli, Porphyromonas, and Fusobacterium may influence IPF risk. These findings support the salivary microbiome as a potential contributor to respiratory disease pathogenesis and warrant further validation in mechanistic and longitudinal studies.

探讨唾液微生物群丰度与慢性阻塞性肺疾病/特发性肺纤维化之间的因果关系:一项双样本孟德尔随机研究
背景:特发性肺纤维化(IPF)和慢性阻塞性肺疾病(COPD)是具有重叠危险因素但病理不同的进行性肺部疾病。本研究采用双向双样本孟德尔随机化(MR)来探索唾液微生物群丰度与两种疾病风险之间的潜在因果关系。方法:分析唾液微生物群丰度数据集与这两种疾病的正向和反向因果关系。44个数据集中,43个符合工具变量选择的纳入标准。磁共振分析采用逆方差加权(IVW)、MR- egger、加权中位数和加权模式方法。斯泰格滤波证实了方向性。敏感性分析包括Cochran’s Q、MR-Egger截距、MR-PRESSO和leave- out,以评估异质性、多效性和个体变异的影响。结果:在前方MR中,较高的小虫种丰度与COPD风险降低显著相关(IVW OR = 0.9546, 95% CI = 0.9224 ~ 0.9879, P = 0.0020;调整P = 0.019)。杆菌、卟啉单胞菌和梭杆菌与IPF呈负相关,但经过多次测试校正后,这些负相关并不显著。所有关键关联均通过Steiger方向性检验,未发现水平多效性或异质性的证据。在反向MR中,COPD与牙周病丰度呈名义上的正相关。结论:本探索性研究提示特定唾液微生物群与慢性呼吸道疾病之间存在潜在的方向性关联。小孢子虫的丰度可能对COPD有保护作用,而芽孢杆菌、卟啉单胞菌和梭杆菌可能影响IPF的风险。这些发现支持唾液微生物组作为呼吸系统疾病发病机制的潜在贡献者,并需要在机制和纵向研究中进一步验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信